2020
DOI: 10.1016/j.cej.2020.124130
|View full text |Cite
|
Sign up to set email alerts
|

Dopant-free methoxy substituted copper(II) phthalocyanine for highly efficient and stable perovskite solar cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
18
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 36 publications
(18 citation statements)
references
References 31 publications
0
18
0
Order By: Relevance
“…A great number of studies have validated the feasibility and effectiveness of the substitution with other dopant-free organic HTMs for spiro-OMeTAD to raise moisture stability (Figure a), including copper­(II) phthalocyanine with butoxy groups (CuPc-OBu), nickel phthalocyanine (NiPc) abbreviated NiPc-(OBu) 8 with vanadium­(V) oxide (V 2 O 5 ), copper­(II) phthalocyanine (CuPc-(OMe) 8 ), zinc­(II) phthalocyanine derivative (Me 6 Bu-ZnPc), DMZ (consisting of four triphenylamine units as side arms and a bifluorenylidene as the core unit), YC-1 based on the 4-dicyanomethylene-4 H -cyclopenta­[2,1-b;3,4-b′]­dithiophene, 4,4-dimethoxytriphenylamine (Z30), P3HT/graphene, and P3HT with nonperipheral octamethyl-substituted copper­(II) phthalocyanine (N-CuMe2Pc). All the PSCs with these organic HTLs have achieved outstanding stability. However, the PCEs of the devices with these organic HTLs are low.…”
Section: Dopant and Alternative Engineeringmentioning
confidence: 99%
“…A great number of studies have validated the feasibility and effectiveness of the substitution with other dopant-free organic HTMs for spiro-OMeTAD to raise moisture stability (Figure a), including copper­(II) phthalocyanine with butoxy groups (CuPc-OBu), nickel phthalocyanine (NiPc) abbreviated NiPc-(OBu) 8 with vanadium­(V) oxide (V 2 O 5 ), copper­(II) phthalocyanine (CuPc-(OMe) 8 ), zinc­(II) phthalocyanine derivative (Me 6 Bu-ZnPc), DMZ (consisting of four triphenylamine units as side arms and a bifluorenylidene as the core unit), YC-1 based on the 4-dicyanomethylene-4 H -cyclopenta­[2,1-b;3,4-b′]­dithiophene, 4,4-dimethoxytriphenylamine (Z30), P3HT/graphene, and P3HT with nonperipheral octamethyl-substituted copper­(II) phthalocyanine (N-CuMe2Pc). All the PSCs with these organic HTLs have achieved outstanding stability. However, the PCEs of the devices with these organic HTLs are low.…”
Section: Dopant and Alternative Engineeringmentioning
confidence: 99%
“…Recently, perovskite solar cells (PSCs) came out as forefront candidate in the field of photovoltaic devices. [ 1–12 ] In just less than a decade, both categories of PSCs, conventional (n‐i‐p) and inverted (p‐i‐n) architectures have already achieved 25.3% and 22.3% certified power conversion efficiencies (PCEs), respectively. [ 10,12 ] Even though in terms of PCE, the inverted PSCs are slightly behind, but hold many advantages with its counterpart, such as hysteresis‐free device operation and all‐solution process fabrication conditions with low temperature requirements.…”
Section: Figurementioning
confidence: 99%
“…[ 15 ] Consequently, it is highly demanded to replace the traditional‐doped Spiro‐OMeTAD by other dopant‐free HTMs for improved efficiency and stability of PSCs. [ 16,17–21 ] In this regard, there are a bunch of studies showing the possibility of molecular engineering on HTMs with very high performance. [ 14,22–24 ] Examples, such as the triazatruxene‐based KR321 (19.03%), [ 25 ] the spiro[fluorine‐9,9′‐xanthene]‐based N 2, N 2, N 7, N 7‐tetrakis(4‐methoxyphenyl)‐3′,6′‐bis(pyridin‐4‐ylmethoxy) spiro[fluorene‐9,9′‐xanthene]‐2,7‐diamine (19.5%), [ 26 ] the truxene‐based Trux‐OMeTAD (18.6%), [ 27 ] the quinolizino acridine incorporating FA‐CN (18.9%), [ 28 ] heteroacene‐based m ‐methoxy‐arylamine‐based di(1‐benzothieno)[3,2‐ b :2′,3′‐ d ]pyrrole (18.09%), [ 29 ] M7‐TFSI containing benzodithiophene and benzothiadiazole (17.4%), [ 30 ] triarylamine‐based TPAC3M (17.54%), [ 31 ] pyridine‐based D105 (17.40%) and D106 (18.24%), [ 32 ] cyclohexylidene‐derivative 4,4′‐cyclohexylidenebis[ N , N ‐bis(4‐methylphenyl) benzenamine] (p‐i‐n type; 18.80%), [ 33 ] and other types of small‐molecule HTMs, [ 23,24 ] all exhibit the PCE of >17% without the need for dopants/additives.…”
Section: Introductionmentioning
confidence: 99%